Literature DB >> 8597882

Auranofin inhibits calcium uptake into opsonized-zymosan-stimulated neutrophils obtained from rats.

K Ishitani1, A Matsuura, H Honda.   

Abstract

In order to study the pharmacological action site of auranofin during the functional suppression of leukocytes, especially neutrophils, we investigated the influence of auranofin on the calcium-45 (45Ca2+) uptake into peripheral blood neutrophils and peritoneal resident macrophages isolated from normal and adjuvant-induced arthritis (AA) rats. Calcium-45 uptake into neutrophils and macrophages obtained from normal and AA rats was increased by stimulation with opsonized-zymosan, while auranofin inhibited the increase in the 45Ca2+ uptake into neutrophils, but not into macrophages. There was a tendency that auranofin more strongly inhibited the increase in the 45Ca2+ uptake into neutrophils obtained from AA rats than normal rats, but no statistically significant difference between them was observed in the inhibitory potency of auranofin. From these results, it is suggested that auranofin would show anti-rheumatic and anti-inflammatory effects by the inhibition of Ca2+ uptake into neutrophils which infiltrate into local lesions during the early and active phases of rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8597882     DOI: 10.1007/bf01837914

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  22 in total

Review 1.  Epstein-Barr virus infection and autoimmunity in rheumatoid arthritis.

Authors:  P Venables
Journal:  Ann Rheum Dis       Date:  1988-04       Impact factor: 19.103

2.  Modulation of neutrophil functions by auranofin. Studies on effects in vitro and in rheumatoid arthritis patients.

Authors:  I Hafström; A M Udén; J Palmblad
Journal:  Scand J Rheumatol       Date:  1983       Impact factor: 3.641

3.  Direct demonstration of increased intracellular concentration of free calcium in rabbit and human neutrophils following stimulation by chemotactic factor.

Authors:  J R White; P H Naccache; T F Molski; P Borgeat; R I Sha'afi
Journal:  Biochem Biophys Res Commun       Date:  1983-05-31       Impact factor: 3.575

4.  Determination of T lymphocyte subpopulations by monoclonal antibodies in rheumatoid arthritis. Influence of immunomodulating agents.

Authors:  E M Veys; P Hermanns; G Goldstein; P Kung; J Schindler; J Van Wauwe
Journal:  Int J Immunopharmacol       Date:  1981

5.  Ca2+ and Ca2+ channel antagonists in the control of human small cell lung carcinoma cell proliferation.

Authors:  M G Cattaneo; M Gullo; L M Vicentini
Journal:  Eur J Pharmacol       Date:  1993-11-15       Impact factor: 4.432

6.  Separation and characterization of human neutrophil granules.

Authors:  B C West; A S Rosenthal; N A Gelb; H R Kimball
Journal:  Am J Pathol       Date:  1974-10       Impact factor: 4.307

7.  Calcium responses elicited by nucleotides in macrophages. Interaction between two receptor subtypes.

Authors:  S R Alonso-Torre; A Trautmann
Journal:  J Biol Chem       Date:  1993-09-05       Impact factor: 5.157

8.  Depressed exocytosis by rheumatoid neutrophils in vitro.

Authors:  C A Minty; N D Hall; P A Bacon
Journal:  Rheumatol Int       Date:  1983       Impact factor: 2.631

9.  Effect of auranofin on autoimmune disease in a mouse model.

Authors:  T Fujitsu; S Sakuma; N Seki; H Senoh; J Mori; H Kikuchi
Journal:  Int J Immunopharmacol       Date:  1986

10.  Effects of gold compounds on the function of phagocytic cells. I. Suppression of phagocytosis and the generation of chemiluminescence by polymorphonuclear leukocytes.

Authors:  P Davis; C L Miller; A S Russell
Journal:  J Rheumatol Suppl       Date:  1982 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.